Express test for NT-proBNP competitive detection based on lateral flow immunoassay using silanized fluorescent quantum dots

Express test for NT-proBNP competitive detection based on lateral flow immunoassay using silanized fluorescent quantum dots

This paper describes the step-by-step development and the application of a lateral flow immunoassay (LFIA) for the detection of the N-terminal pro-brain natriuretic peptide (NT-proBNP). NT-proBNP is widely used as a biomarker for diagnosing heart failure and other cardiac dysfunctions, distinguishin...

Full description

Bibliographic Details
Main Authors:	Olga A. Goryacheva, Alina A. Kokorina, Yulia A. Podkolodnaya, Pradyumna K. Mishra, Irina Yu. Goryacheva
Format:	Article
Language:	English
Published:	Elsevier 2023-08-01
Series:	Talanta Open
Subjects:	N-terminal pro-brain natriuretic peptide Competitive immunoassay Heart failure biomarker detection Quantum dots Lateral flow immunoassay
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666831923000073

Similar Items

Performance of the Abbott Architect Immuno-Chemiluminometric NT-proBNP Assay
by: Chin-Shern Lau, et al.
Published: (2022-05-01)

NT-proBNP: A Biochemical Marker of Maternal Complications in Pre-eclampsia
by: Supriya Kumari, et al.
Published: (2017-11-01)

Differences in NT‐proBNP Response and Prognosis in Men and Women With Heart Failure With Reduced Ejection Fraction
by: Melissa A. Daubert, et al.
Published: (2021-05-01)

Development of an NT-ProBNP Assay Reagent Based on High Specific Activity Alkaline Phosphatase CmAP and an Improved Coupling Method
by: Hai-Chao Li, et al.
Published: (2020-12-01)

Usefulness of NT-proBNP in the follow-up of patients after myocardial infarction
by: Radosavljević-Radovanović Mina, et al.
Published: (2016-01-01)

Can NT-proBNP Levels Be an Early Biomarker of Reduced Left Ventricular Ejection Fraction in Preterm Infants?
by: Ya-Lan Lin, et al.
Published: (2022-07-01)

Dot-dye-immunoassay for the diagnosis of schistosomiasis mansoni
by: Ana Lúcia Teles Rabello, et al.
Published: (1992-06-01)

The integration of BNP and NT-proBNP into clinical medicine
by: Swiss Medical Weekly
Published: (2007-01-01)

Associations between diet quality and NT-proBNP in U.S. adults, NHANES 1999-2004
by: Ping Yang, et al.
Published: (2023-12-01)

NT‐proBNP and Risk of Dementia in a General Japanese Elderly Population: The Hisayama Study
by: Takuya Nagata, et al.
Published: (2019-09-01)

Adenotonsiller Hipertrofi Olan Çocuklarda Adenotonsillektominin N-Terminal Pro-Beyin Natriüretik Peptid (NT-ProBNP) Düzeylerine Etkileri
by: Metin Çeliker, et al.
Published: (2017-11-01)

Serum brain natriuretic peptide (BNP) and N-terminal brain natriuretic peptide (NT-proBNP) in heart valve disease
by: J.A. Moolman, et al.
Published: (2017-04-01)

Fasting Plasma Ketone Bodies Are Associated with NT-proBNP: A Potential Mechanism to Provide Fuel for the Failing Heart
by: Constantin L. Palm, et al.
Published: (2024-03-01)

NT-proBNP level in stage 3-4 chronic kidney disease and mortality in long-term follow-up: HAPPY study subgroup analysis
by: Mustafa Aytek Şimşek, et al.
Published: (2020-07-01)

Can NT-proBNP be used as a criterion for heart failure hospitalization in emergency room?
by: Tuba Cimilli Ozturk, et al.
Published: (2011-01-01)

Simple and sensitive detection of triazophos pesticide by using quantum dots nanobeads based on immunoassay
by: Yun Liao, et al.
Published: (2019-01-01)

The diagnostic significance of NT-proBNP and troponin I in emergency department patients presenting with palpitations
by: TarÄ±k Ocak, et al.
Published: (2013-04-01)

Usefulness of NT-proBNP in dogs with heartworm: could this biomarker be useful to evaluate pulmonary hypertension?
by: Noelia Costa-Rodríguez, et al.
Published: (2023-08-01)

Predictive Model for Preeclampsia Combining sFlt-1, PlGF, NT-proBNP, and Uric Acid as Biomarkers
by: Carmen Garrido-Giménez, et al.
Published: (2023-01-01)

A Group of Complexes Based on PAMAM and Quantum Dots Used in Clinical Immunoassays
by: Yang Liu, et al.
Published: (2020-04-01)

Association between vitamin D levels and left ventricular function and NT-proBNP levels among thalassemia major children with iron overload
by: Leny Ambarwati, et al.
Published: (2016-01-01)

Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP – A narrative review
by: Brian Kerr, et al.
Published: (2022-12-01)

Immunochemistry of solid-phase immunoassay /
by: Butler, John E.
Published: (1991)

NT-proBNP in Different Patient Groups of COPD: A Systematic Review and Meta-Analysis
by: Su X, et al.
Published: (2023-05-01)

NT‐proBNP as a Mediator of the Racial Difference in Incident Atrial Fibrillation and Heart Failure
by: Isaac R. Whitman, et al.
Published: (2019-04-01)

ANALYSIS OF CHANGE IN NT-proBNP AFTER ANGIOTENSIN RECEPTOR BLOCKER (ARB) THERAPY IN PATIENT WITH HEART FAILURE
by: Intan Kusuma Dewi, et al.
Published: (2017-08-01)

Early Predictive Value of NT-proBNP Combined With Echocardiography in Anthracyclines Induced Cardiotoxicity
by: Yingjun Dong, et al.
Published: (2022-07-01)

N‐Terminal Pro–Brain Natriuretic Peptide (NT‐proBNP) Levels are Increased in Patients With Transient Ischemic Attack Accompanied by Nonfocal Symptoms
by: Gerben J. J. Plas, et al.
Published: (2015-12-01)

The relationship between serum NT-pro BNP and the severity of the COPD exacerbation
by: Farnoosh Ebrahimzadeh, et al.
Published: (2018-06-01)

Prognostic value of NT-proBNP levels in the acute phase of sepsis on lower long-term physical function and muscle strength in sepsis survivors
by: Carlo Custodero, et al.
Published: (2019-06-01)

Superior prognostic value of soluble suppression of tumorigenicity 2 for the short-term mortality of maintenance hemodialysis patients compared with NT-proBNP: a prospective cohort study
by: Zhiyu Wang, et al.
Published: (2020-01-01)

Immunoassay /
by: Diamandis, Eleftherios P., et al.
Published: (1996)

Relationship between renalase and N-terminal pro-B-type Natriuretic Peptide (NT pro-BNP) in haemodialysis patients
by: Marcin Dziedzic, et al.
Published: (2014-03-01)

NT‐proBNP/BNP ratio for prognostication in European Caucasian patients enrolled in a heart failure prevention programme
by: Claire Sweeney, et al.
Published: (2021-12-01)

DOT-IMMUNOASSAY USING GOLD NANOPARTICLE MARKED COLLOID GOLD FOR THE DETECTION OF BOTULINIC TOXIN IN CLINICAL MATERIAL AND FOOD PRODUCTS
by: T. Yu. Zagoskina, et al.
Published: (2017-08-01)

Elevated NT-proBNP levels are associated with CTP ischemic volume and 90-day functional outcomes in acute ischemic stroke: a retrospective cohort study
by: Xiaozhu Shen, et al.
Published: (2022-09-01)

ANALYSIS OF CHANGES IN THE SERUM LEVEL NT-proBNP AFTER ACE INHIBITORS THERAPY IN PATIENTS WITH HEART FAILURE
by: Halla Hisan Hartoto, et al.
Published: (2017-08-01)

Application of Dot-Immunoassay for Detection of Plague Agent Antigens in the Field Samples
by: O. A. Noskova, et al.
Published: (2014-09-01)

Correlation of Suppression of Tumourigenicity 2 with hsCRP, NT-proBNP and Left Ventricular Ejection Fraction in Patients with Myocardial Infarction
by: Mainuddin Khan, et al.
Published: (2022-09-01)

Correlation analysis between Scr，hs-cTnT，NT-proBNP and major cardiovascular adverse events in patients with burn injury
by: Xiong Lei, Luo Weiqing, Zhang Shaoheng
Published: (2024-01-01)